Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

More antiobesity proteins reported by Lilly

Nov. 25, 1996

Genentech advances NGF through the clinical development pipeline

Nov. 22, 1996

Cortecs plans oral insulin studies in diabetic patients

Nov. 22, 1996

Another French market introduction for Lescol

Nov. 22, 1996

Alkermes and Genentech expand collaboration for sustained-release human GH

Nov. 22, 1996

New impotence treatment deemed approvable by FDA

Nov. 22, 1996

Antidiabetic agents reported by Terumo

Nov. 22, 1996

First regulatory approval for impotence treatment

Nov. 21, 1996

Thrombopoietic activity of PEG-rHuMGDF established in cancer patients

Nov. 21, 1996

Solvay and TheraTech end HRT collaboration

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...